Screener
Zevra Therapeutics, Inc. ZVRA Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $8.75M-88.3% | $37.89M+1,323% | $12.17M+134% | -$544K+98.4% | $74.71M+475% | ||
| $364K-78.0% | $368K-77.7% | $362K-78.0% | $392K-75.8% | $1.65M+5.7% | ||
| $2.97M+20.5% | $3.11M-0.3% | $4.28M+6.6% | $2.77M-54.8% | $2.46M-6.4% | ||
| $17.03M+573% | $6.14M+175% | —— | —— | -$3.6M+81.2% | ||
| $217K+1.9% | $35K-64.6% | $0— | $554K— | $213K— | ||
| $31.45M+164% | $79.62M+655% | $227K+104% | —— | $11.93M+9,351% | ||
| —— | $60.09M— | $0— | $0— | $0-100% | ||
| —— | -$52.8M-3,386% | $2.55M+220% | $6.53M-89.9% | $1.38M-91.0% | ||
| $49.73M+379% | $33.19M+834% | $7.97M+139% | $6.73M-54.5% | $10.37M+389% | ||
| $16.82M+541% | $6.11M+173% | —— | —— | -$3.81M+80.0% |
FAQ
- Where does Zevra Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Zevra Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
